← All Chain Bridge I filings

Chain Bridge I 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
CBGGF
Chain Bridge I
10-K: Chain Bridge I Faces Delisting, Liquidity Concerns Amid Search
Chain Bridge I, a blank check company, reported recurring losses, a working capital deficit, and delisting from Nasdaq to OTCID, raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
CBGGF
Chain Bridge I
10-K: Chain Bridge I Faces Delisting and Financial Headwinds After Business Combination Termination
Chain Bridge I, a blank check company, reported a net loss for 2024, a significant working capital deficit, and the termination of its proposed business combination with Phytanix Bio, leading to its delisting from Nasdaq and raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
CBGGF
Chain Bridge I
10-K: Chain Bridge I Outlines Securities in Annual 10-K Filing
Chain Bridge I's annual 10-K filing details the terms of its securities, including Class A and Class B ordinary shares, warrants, and related agreements, as the company seeks a business combination.